US Stock MarketDetailed Quotes
KROS Keros Therapeutics
- 15.920
- +0.090+0.57%
Close Jan 2 16:00 ET
- 15.900
- -0.020-0.13%
Post 20:01 ET
644.88MMarket Cap-3.05P/E (TTM)
16.700High15.820Low524.30KVolume15.950Open15.830Pre Close8.45MTurnover1.48%Turnover RatioLossP/E (Static)40.51MShares73.00052wk High1.21P/B563.10MFloat Cap15.33052wk Low--Dividend TTM35.37MShs Float88.800Historical High--Div YieldTTM5.56%Amplitude15.330Historical Low16.116Avg Price1Lot Size
Keros Therapeutics Stock Forum
Sign in to post a comment
$Keros Therapeutics (KROS.US)$ turn off your stop losses
1
$Keros Therapeutics (KROS.US)$ what happened 75% down?
1
$Keros Therapeutics (KROS.US)$ this will go back to 40s by Monday 👀👀👀
1
1
🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...
17
3
3
NHP data from $Regeneron Pharmaceuticals (REGN.US)$ 's new slide deck is very relevant for the weight loss space.
Combining pure anti-Myostatin antibodies with Semaglutide was marginally effective in NHPs in preventing muscle loss. I believe that for that reason, $Scholar Rock (SRRK.US)$ and probably also $Biohaven (BHVN.US)$ are likely to disappoint.
Additionally blocking other ligands like Activin A dramatically improves body composition. That is what $Eli Lilly and Co (LLY.US)$ , $Keros Therapeutics (KROS.US)$ ...
Combining pure anti-Myostatin antibodies with Semaglutide was marginally effective in NHPs in preventing muscle loss. I believe that for that reason, $Scholar Rock (SRRK.US)$ and probably also $Biohaven (BHVN.US)$ are likely to disappoint.
Additionally blocking other ligands like Activin A dramatically improves body composition. That is what $Eli Lilly and Co (LLY.US)$ , $Keros Therapeutics (KROS.US)$ ...
3
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Tooleye3 OP : - YouTube